Novel 99mTc-labeled Somatostatin Antaginosts in the Diagnostic Algotithm of Neuroendocrine Neoplasms
NCT05871320
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Neuroendocrine Tumors
Interventions
DRUG:
[99mTc]Tc-TECANT1
Sponsor
Jagiellonian University
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]